Navigation Links
Neptune Technologies expands into medicinal markets in Asia Pacific
Date:3/25/2008

Commercial pharmaceutical partner, Inovail, successfully launches

OmegaGen(R) in Australia and New Zealand

LAVAL, QC, March 25 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) and its commercial pharmaceutical partner Inovail Pty Ltd ("Inovail"), announce the successful launch of OmegaGen(R) as a complementary medicine in Australia and New Zealand. Neptune foresees this market entry as a commercial portal for Neptune into large medicinal Asian Pacific markets.

Inovail in collaboration with PharmaLink, which ranks amongst the top five sales organizations in the Australian pharmaceutical industry, is promoting and marketing OmegaGen(R). OmegaGen(R), containing Neptune Krill Oil (NKO(R)), is being initially distributed through retail pharmacies, health food stores and healthcare professionals. As a short-term marketing objective, Inovail seeks to distribute OmegaGen(R) in three thousand pharmacies.

"Our strong clinical evidence and established credibility in the industry will help Inovail's brands achieve high levels of medical endorsement as natural, evidence-based options for the improvement of cognitive function, and chronic cholesterol and inflammation management," said Dr. Tina Sampalis, Chief Scientific Officer of Neptune. "Additional product launches to expand the complementary medicine franchise are planned in the following few months. This strategy should allow Neptune to take full advantage of these products in a combined potential market worth over 300 million$."

"We are very excited to be the first to launch Neptune Krill Oil, an exceptional and innovative product. We expect to gain rapid and deep penetration of the pharmacy and other healthcare channels," said Dr. Peter Mayrick from Inovail. "Our market research has indicated that, when health professionals and consumers of omega-3 fatty acids are presented the clinical evidence for Neptune Krill
'/>"/>

SOURCE NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Neptune Reports Year End Financial Results - Neptune Records 18% Sales Increase and 43% EBITDA Increase in Year End Results
2. Neptune Technologies & Bioressources Inc. Reports First Quarter Results and Business Update
3. Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board
4. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
5. Neptune Technologies & Bioressources Inc. obtains Complementary Medicine approval in Australia for NKO(R)
6. Neptune Technologies receives GRAS notification in the United States
7. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
8. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
9. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
10. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
11. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ue Marble Energy Corp. announced today that the co...(OPDA) were recently awarded $2 million by Washing...d (CERB) in a private/public partnership to constr...inery in Lincoln County, WA. ,, "This investm...r biorefinery and bring over 70 green jobs to Linc...
(Date:11/24/2009)... been met for patients with advanced-stage, or ...Nov. 24 /PRNewswire-FirstCall/ - AEterna Zentaris ... global biopharmaceutical company focused on endoc...e efficacy data from a Phase 2 study with its targ...ly AN-152), in patients with advanced or recurrent...
(Date:11/24/2009)...e-FirstCall/ -- Shire plc (LSE: SHP,NASDAQ: SHPG...y, today,announced that it has submitted a MAA to ...fa, the company,s enzyme replacement therapy in de...ase. This is the third marketing,application for v...evious,submissions in the United States and Canada...
(Date:11/24/2009)...Newswire-FirstCall/ -- Genomic Health, Inc. (Nasda...ic Health,s Executive Chairman, will present at th... in New York City on Tuesday, December 1, 2009 at ...quently archived webcast of the presentation, visi...,s website at http://investor.genomichealth.com ....
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...orks Corp. has completed an SAS 70 Type II Audit ...d on Monday. , ,The SAS 70 Type IIauditand the Sys...ng benchmarks, formulated by the American Institut...ervice providers can report control activities and...SAS 70 Audit is the primary means by which a servi...
... joined the board of directors of Neurognostics, ...stics, which spun out of the Medical College of Wi...ng (fMRI) products and services , ,Silva-Craig is ...on Inc., which he joined in March, 2001. Emageon ...rvices. Prior to joining Emageon, Silva-Craig held...
...ications and other communications services will be... as representatives of nine western Wisconsin coun...art of the Synergy 2005 Conference , which will b...uncheon. , ,The counties engaged in the process ar..., Pierce, Polk and St. Croix. , ,Conference organi...
Other Biology Technology:Telecom issues are among focus of upcoming western Wisconsin conference 2Telecom issues are among focus of upcoming western Wisconsin conference 3
(Date:11/26/2009)...DGE, Mass. (November 26, 2009) Whitehead research...r human cells to pinpoint specific genes and prote... Science . , In most human cell cultures genes ...father and one from the mother. Gene inactivation ...one copy is inactivated, the second copy usually r...
(Date:11/26/2009)...methicillin-resistant Staphylococcus Aureus ) and...tion as low-temperature plasma prototype devices h...unfailing bactericidal cocktails. , Two prototyp...isinfection of healthy skin (e.g. hands and feet) ...pose a lethal threat; and another to shoot bacteri...
(Date:11/25/2009)...n, a hormone produced in the stomach, may be used ...f Parkinson,s disease, Yale School of Medicine res...ssue of the Journal of Neuroscience . , Parkins...ne neurons in an area of the midbrain known as the...ne production. Reduced production of dopamine in ...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Hormone ghrelin can boost resistance to Parkinson's disease 2Ovarian transplantation 3A New technique gives greatly improved results in this delicate operation 9049 1Ovarian transplantation 3A New technique gives greatly improved results in this delicate operation 9049 2Ovarian transplantation 3A New technique gives greatly improved results in this delicate operation 9049 3Ovarian transplantation 3A New technique gives greatly improved results in this delicate operation 9049 4Working to conserve endangered Playboy bunnies 9046 1Working to conserve endangered Playboy bunnies 9046 2Kendle Names Jarrod Pontius Chief Legal Officer 12829 1Kendle Names Jarrod Pontius Chief Legal Officer 12829 2
...tiple strains of the flu virus, circulating in a p...nes and create a new virus, one capable of infecti...he open-access journal PLoS Biology. This finding ...which viral strains will attack during upcoming fl..., In the first large-scale effort to sequence the ...
...a clever bit of biology called site-specific recom...to another organism, and perform a sort of graftin...into a chromosome of the target cell. The process ...at cause drug resistance or transmit viruses that ...kemias or other cancers. , But what do the surgeon...
... research on a bacterium that can survive encounte...ned scientists, belief that these plentiful white ... our immune system will permit or prevent bacteria...released today online in The Journal of Immunology...ories (RML), part of the National Institute of All...
Other Biology News:Enlisting genomics to understand flu evolution 2Brown-Harvard team solves mobile DNA's surgical sleight-of-hand 2Scientists reveal how disease bacterium survives inside immune system cell 2Scientists reveal how disease bacterium survives inside immune system cell 3
Fentanyl ELISA Kit, Single from Bio-Quant Inc.
Dengue Virus IgG ELISA Kit, Single from Bio-Quant Inc.
Human Laminin ELISA Kit, QuantiMatrix from Upstate
Rat Osteopontin EIA Kit from Assay Designs/Stressgen Bioreagents
Biology Products: